CHO Pharma, Inc. (TPEX:6586)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
34.90
-0.25 (-0.71%)
Oct 31, 2025, 2:58 PM CST
-0.71%
Market Cap7.47B
Revenue (ttm)3.21M
Net Income (ttm)-230.38M
Shares Out214.01M
EPS (ttm)-1.08
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume149,936
Average Volume212,136
Open35.15
Previous Close35.15
Day's Range34.65 - 35.25
52-Week Range34.65 - 68.80
Beta-0.52
RSI32.96
Earnings DateNov 13, 2025

About CHO Pharma

CHO Pharma, Inc., engages in research and development of biotechnology in Taiwan. It develops glycoengineering platform technologies, including SAR-based glycoengineered biobetters; glycosite-specific antibody-drug conjugates (ADCs); novel antibodies and vaccines targeting novel carbohydrate antigens; and programs using its glycoengineering technologies. The company also provides CHOptimax, an in vitro enzymatic one-pot process that converts naked antibodies into glycoengineered biobetter or ADC. In addition, the company develops CHO-H01, which... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2012
Country Taiwan
Stock Exchange Taipei Exchange
Ticker Symbol 6586
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.